Henderson Molly 4/A
4/A · Phathom Pharmaceuticals, Inc. · Filed Jul 21, 2023
Insider Transaction Report
Form 4/AAmended
Henderson Molly
CFO and CBO
Transactions
- Award
Common Stock
2023-07-14+25,000→ 95,180 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted on July 14, 2023. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of July 14, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]This amendment is being filed to correct the transaction price included in the Form 4 filed on behalf of the Reporting Person on July 17, 2023.
- [F3]Includes 1,674 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2023.